PULIKE(SH:603566) Ge Long Hui·2026-01-08 08:21Core Viewpoint - The company, Pulaike (603566.SH), has received approval from the Ministry of Agriculture and Rural Affairs for its new veterinary drug, "Fluralaner Chewable Tablets," which is aimed at treating external parasites in dogs [1] Group 1: Product Approval - The new veterinary drug has been officially registered and is set to be effective as of January 7, 2026, following the issuance of the New Veterinary Drug Registration Certificate [1] - The approval was granted based on the regulations outlined in the Veterinary Drug Management Regulations and the Veterinary Drug Registration Measures [1] Group 2: Indications and Usage - The drug is indicated for the treatment of external parasites in dogs, specifically targeting ticks (Rhipicephalus sanguineus) and fleas (Ctenocephalides felis, Ctenocephalides canis) [1] - It can also be used as part of a treatment plan for flea allergy dermatitis [1]